Evidence status: PUBLIC INSTITUTIONAL FORM / LAST UPDATED 11/01/2018 / CURRENT USE UNRESOLVED. Oklahoma Spine & Brain Institute continues to host its Opioid Therapy Patient-Provider Agreement. The document itself states a last-updated date of November 1, 2018. Seeds of Vice has not yet established that this exact version is the agreement currently issued to patients.

Quick read

The agreement covers one-practice prescribing, pharmacy use, refills, lost or stolen medication, pill counts, urine or blood testing, naloxone, appointment compliance, pregnancy, tapering, and termination.

Who is on the provider side

The document is an Oklahoma Spine & Brain Institute form and is signed in relation to the patient’s treating provider. Because this exact version’s current clinical use is unresolved, the page does not attribute it to any current physician beyond the institution itself.

Terms that matter most

  • The form restricts pain medication to the practice except as authorized.
  • Lost, stolen, destroyed, or prematurely used medication does not permit early refills under the agreement.
  • Random pill counts and urine or blood testing may be used; refusal or inconsistent results can lead to dismissal.
  • The form states a practice dosing policy expressed as a morphine-equivalent ceiling and describes it in relation to CDC guidance and state law.
  • The agreement includes taper/weaning and termination provisions.

Current-law caution

A practice dosing policy is not the same thing as a statewide legal dose ceiling. Oklahoma’s enacted 2026 SB 1642, effective November 1, 2026, expressly states that the opioid-prescribing section does not require forced tapering and calls for individualized treatment without an administrative or codified limit more restrictive than FDA approval. Because this OSBI form is dated 2018, its dose-limit language requires current-context labeling.

Primary sources

← Oklahoma Contract-for-Care Evidence Library

Reviewed: October 4, 2026.

Evidence boundary: Hosting proves public availability, not that this 2018 version remains the currently executed form.